Related Articles
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1<sup>low/negative</sup> non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapy
Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation
Distribution characteristics and clinical significance of infiltrating T cells in the tumor microenvironment of pancreatic cancer
Lentivirus‑mediated RNA interference targeting programmed death receptor ligand 1 increases the immunologic anti‑tumor effect of dendritic cell vaccination against pancreatic cancer in SCID‑hu mice
Anti‑VEGF antibody triggers the effect of anti‑PD‑L1 antibody in PD‑L1<sup>low</sup> and immune desert‑like mouse tumors